Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
NeoGenomics, Inc. (NEO) had Cost of Goods Sold of $413.04M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$727.33M |
|
$-108.03M |
|
|
Cost of Goods Sold |
$413.04M |
$314.29M |
|
$843.21M |
|
$-115.88M |
|
$5.61M |
|
$-110.27M |
|
$-110.27M |
|
$-108.03M |
|
$-108.03M |
|
$-108.03M |
|
$-108.03M |
|
$-115.88M |
|
$-46.06M |
|
128.10M |
|
128.10M |
|
$-0.84 |
|
$-0.84 |
|
| Balance Sheet Financials | |
$376.29M |
|
$84.83M |
|
$983.54M |
|
$1.36B |
|
$88.30M |
|
$341.86M |
|
$434.97M |
|
$523.27M |
|
$836.56M |
|
$25.69M |
|
$836.56M |
|
128.99M |
|
| Cash Flow Statement Financials | |
$5.23M |
|
$-12.34M |
|
$-200.29M |
|
$367.01M |
|
$159.62M |
|
$-207.39M |
|
$41.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
0.29 |
|
0.41 |
|
43.21% |
|
-15.93% |
|
-15.93% |
|
-6.33% |
|
-15.16% |
|
-14.85% |
|
$-19.71M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
14.46 |
|
4.57 |
|
79.91 |
|
-12.91% |
|
-420.50% |
|
-7.94% |
|
-9.17% |
|
$6.49 |
|
$-0.15 |
|
$0.04 |
|